Caring Health

Cherishing Life, AndProtecting The EnvironmentFor A Better World!

2025

Semi-annual Report

Winner Medical Co., Ltd.

Brand Vision

Caring Health, Cherishing Life, and Protecting the Environment for A Better World.

Core Business Principles

Quality over the Profit, Brand over the Speed, Social Value over the Corporate Value

Brand EthicsIntegrity in Operation, Respect for Consumers, Fair Competition, Social Responsibility,

Intellectual Property Rights, Continuous Improvement

Section IImportant Notes,Contents, andDefinitions

Cotton Thrives, Deserts Retreat.

Section I Important Notes, Contents, and Definitions

Important Notes

The Board of Directors, the Supervisory Committee, and the Directors, Supervisors, and seniormanagement of the Company guarantee that this semi-annual report is truthful, accurate, andcomplete; it contains no false records, misleading statements, or significant omissions; and theybear individual and joint legal liabilities.Li Jianquan, the Company’s principal executive officer, Fang Xiuyuan, financial controller andZhao Yan, accounting supervisor (chief accounting officer) declare that they guarantee thetruthfulness, accuracy, and completeness of the financial report in this semi-annual report.All Directors have attended the Board of Directors meeting to review this semi-annual report.The forward-looking statements contained in this semi-annual report, regarding futuredevelopment strategies, performance plans, and other similar matters, represent the Company’sgoals and are of a planning nature. Their realization depends on various factors, includingchanges in market conditions, and therefore involves uncertainties. These statements do notconstitute a forecast of the Company’s future profitability nor do they represent a substantivecommitment to investors or other stakeholders. Both investors and other stakeholders shouldmaintain sufficient awareness of the risks involved and understand the differences between plans,forecasts, and commitments. Investors are advised to exercise caution and be aware of investmentrisks.The profit distribution plan approved at this Board of Directors meeting is as follows: based on582,329,808 shares, a cash dividend of RMB4.50 (tax inclusive) for every 10 shares will bedistributed to all shareholders. No bonus shares (tax inclusive) will be distributed, and no shareswill be converted from capital reserves.

Section I Important Notes, Contents, and Definitions

CONTENTS

List of Documents Available for Inspection(I) Financial statements signed and sealed by the Company’s principal executiveofficer, financial controller, and accounting supervisor (chief accounting officer).(II) Originals of all documents and announcements of the Company publicly disclosedduring the Reporting Period.

Section I Important Notes, Contents, and Definitions

Definitions

Winner Group, Company

Reporting period

Winner Medical

Purcotton

Longterm Medical

Winner Medical (Hunan)

Winner Guilin

Junjian Medical

GRI

Winner Medical(Huanggang)

Winner Medical (Jiayu)

Winner Medical(Chongyang)

Winner Medical(Jingmen)

Yuan

Section II Company Profile and Key Financial Indicators

PurCotton Surgical Drapeswith FenestrationPurCotton Surgical Cap

PurCotton Surgical CapFace Mask withPurCotton Inner Layer

Face Mask withPurCotton Inner LayerPurCotton SurgicalGown

PurCotton SurgicalGown

PurCotton Non-wovenDressing

PurCotton Non-wovenDressingPurCotton Gauze Product

Series

PurCotton Gauze Product

SeriesPurCotton Radiation-ShieldingNeck Gaiter

PurCotton Radiation-Shielding

Neck GaiterPurCotton SurgicalScrub Suit

PurCotton SurgicalScrub SuitPurCotton Surgical HandTowel

PurCotton Surgical HandTowel

Section IICompany Profileand KeyFinancialIndicators

Section IICompany Profileand KeyFinancialIndicators

Section II Company Profile and Key Financial Indicators

Company OverviewFounded in 1991, Winner Group (300888.SZ) went public on the Shenzhen Stock Exchange in September 2020. Through 34 years of exploration andpractice, it has evolved into a holistic health enterprise, synergistically converging medical innovation and consumer wellness ecosystems. Winner Group,driven by the vision of “Caring Health, Cherishing Life, and Protecting the Environment for A Better World”, owns two major brands: “Winner Medical”and “Purcotton”. Its products cover a wide range of segments including wound care, infection prevention, operating room consumables, personal care,home care, maternity and baby care, and home textiles and apparel. The Company follows the core business principles of “Quality over the Profit, Brandover the Speed, Social Value over the Corporate Value”, guided by a development strategy focused on “Product leadership, Operational excellence,Global vision”. Winner Group is committed to pursuing dual-track advancement in medical and consumer goods sectors; driving collaborative expansionacross domestic and global markets; enabling convergent growth of online and offline channels; upholding altruism and long-termism — committed todelivering safe, premium, cost-effective, and experience-driven products and services for global users

Caring Health, Cherishing Life, and Protecting the Environment for A

Better World.To build a “one-stop solution for medical consumables” through both organic

and inorganic growth

To build a “one-stop solution for medical consumables” through both organic

and inorganic growth

Product Leadership

1)Commitment to innovation in basic materials under the 246+6

principle

2)Focus on core popular products to ensure a leading market

share in strategic categories and drive growth in niche segments

Product Leadership

1)Commitment to innovation in basic materials under the 246+6

principle

2)Focus on core popular products to ensure a leading market

share in strategic categories and drive growth in niche segmentsOperational Excellence

1)Brand advancement with emphasis on continuous

interpretation and communication of brand philosophy andvalues

2)Standardization of basic management processes, digitization

of process management, implementation of intelligent digitalmanagement, and optimization of omni-channel basic operationalmanagement

Operational Excellence

1)Brand advancement with emphasis on continuous

interpretation and communication of brand philosophy andvalues

2)Standardization of basic management processes, digitization

of process management, implementation of intelligent digitalmanagement, and optimization of omni-channel basic operationalmanagement

Global Vision

1)A global vision means having a worldwide vision and paving

the way for robust internationalization

2)Robust internationalization is not simply about exporting

products, but about becoming a truly international brand

Global Vision

1)A global vision means having a worldwide vision and paving

the way for robust internationalization

2)Robust internationalization is not simply about exporting

products, but about becoming a truly international brand

To embrace pure cotton and maximize the potential of each piece of cotton

towards the vision of “Pure Cotton Changes the World”

To embrace pure cotton and maximize the potential of each piece of cotton

towards the vision of “Pure Cotton Changes the World”

Core Business Principles:

Core Business Principles:

Quality over the Profit, Brand over the Speed, Social Value over the Corporate Value

Brand Ethics:

Section II Company Profile and Key Financial Indicators

Product Portfolio

Section II Company Profile and Key Financial Indicators

Supply chain

Global Production Capacity

Establishing a Leading Global Product Supply Chain System

? Winner

? Longterm

? Winner Medical (Hunan)

? Winner Guilin

? GRI

Section II Company Profile and Key Financial Indicators

I. Company Information

Stock Exchange

Chinese Name

Abbreviated Chinese Name (if any)

English Name (if any)

Abbreviated English Name (if any)

Legal Representative

II. Contact Information

Name

Address

Tel.

Email

III. Other Information

1. Contact Information

Whether the Company’s registered address, office address and postal code, company website and email were changed during the reporting period

□Applicable √N/A

There is no change in the Company’s registered address, office address and postal code, Company website and email during the reporting period, asshown in 2024 annual report.

2. Designated Locations for Information Disclosure and for Keeping Records

Whether information disclosure and the place where the semi-annual report is kept were changed during the reporting period

□Applicable √N/A

The name and URL of the stock exchange website and media for publishing the semi-annual report, and the place where the semi-annual report is keptwere not changed during the reporting period. See the 2024 Annual Report for details.

Section II Company Profile and Key Financial Indicators

3. Change of Registration

Whether the registration status was changed during the reporting period

□Applicable √N/A

There were no changes in the Company's registration during the reporting period. See the 2024 Annual Report for details.IV. Key Accounting Data and Financial IndicatorsDoes the Company need to retrospectively adjust or restate accounting data of previous year

□Yes √No

Operating revenue (RMB)

Net profit attributable to shareholders of thelisted company (RMB)

Net profit attributable to shareholders of thelisted company after deducting non-recurringgains and losses (RMB)

Net cash flow from operating activities (RMB)

Basic earnings per share (RMB/share)

Diluted earnings per share (RMB/share)

Weighted average return on net assets

Total assets (RMB)

Net assets attributable to shareholders of thelisted company (RMB)

Note 1: Driven by both endogenous and exogenous growth, operating revenue grew by 31.31% compared with the same period last year. The medical segmentachieved operating revenue of RMB 2.52 billion, representing a year-on-year increase of 46.4% (or 13.2% like-for-like growth excluding GRI contributions).Meanwhile, the consumer goods segment recorded a year-on-year increase of 20.3%.Note 2: Net profit attributable to the parent company, excluding non-recurring items, increased by 40.9% year-over-year. This was primarily driven by revenuegrowth during the period and an increase in net profit attributable to the parent compamy. As non-recurring gains and losses were lower compared with the sameperiod last year, the growth rate of net profit attributable to shareholders after deducting non-recurring items was higher than the growth rate before such deductions.Note 3: Net cash flow from operating activities increased by 75.82% compared to the same period last year, mainly due to the continuous improvement of theCompany’s working capital managementV. Differences in Accounting Data under Domestic and Overseas Accounting Standards

1. Differences in net profit and net assets between financial reports prepared under InternationalAccounting Standards and Chinese Accounting Standards

□Applicable √N/A

The Company had no difference in net profit and net assets between financial reports prepared under International Accounting Standards and ChineseAccounting Standards during the Reporting Period.

Section II Company Profile and Key Financial Indicators

2. Differences in net profit and net assets between financial reports prepared under overseas accountingstandards and Chinese Accounting Standards

□Applicable √N/A

The Company had no difference in net profit and net assets between financial reports prepared under overseas accounting standards and ChineseAccounting Standards during the Reporting Period.VI. Items and Amounts of Non-recurring Gains and Losses

√Applicable □N/A

Unit: RMB

Gains and losses on disposal of non-current assets (including reversal of previously recognizedimpairment losses)

Government grants recognized in profit or loss (excluding those related to the company’s normaloperating activities, consistent with national policy, granted based on established criteria, and having acontinuing impact on the Company’s profit and loss)

Changes in fair value and gains and losses from the disposal of financial assets and financial liabilitiesheld by non-financial enterprises (excluding effective hedging transactions directly related to theCompany’s normal operating activities)

Other non-operating income and expenses, excluding the items above

Less: Income tax effect

Effect on non-controlling interests (after tax)

Total

Details of other items classified as non-recurring gains and losses:

□Applicable √N/A

The Company had no details of other items classified as non-recurring gains and losses.Explanation on circumstances under which items specifically identified as non-recurring gains and losses in the Information Disclosure InterpretativeAnnouncement No. 1 for Companies Publicly Issuing Securities – Non-recurring Gains and Losses are classified as items of recurring gains and losses

√Applicable □N/A

Cotton transportation subsidies

Interest income from large-denominationcertificates of deposit

Section III Management Discussion and Analysis

Section IIIManagementDiscussion andAnalysis

Section III Management Discussion and Analysis

I. Main OperationsThe company shall comply with the disclosure requirements of the “Medical Device Business” in the Self-Regulatory Guidelines for Listed Companieson the Shenzhen Stock Exchange No. 4 – Industry Information Disclosure of the Growth Enterprise Market.：

The Company is subject to the disclosure requirements for “Textile and Apparel Related Business” in the Shenzhen Stock Exchange Listed CompanySelf-Regulation Guidelines No. 3 – Industry Information Disclosure.

(I) Main operations of the CompanyWinner Group, driven by the vision of “Caring Health, Cherishing Life, and Protecting the Environment for A Better World”, owns two major brands:

“Winner Medical” and “Purcotton”, specializing in medical and consumer segments, respectively. With continuous innovation and expansion of ourbusiness scope, our products cover a wide range of segments, including wound care, infection prevention, operating room consumables, personal care,home care, maternity and baby care, and home textiles and apparel. Adhering to the core business principles of “Quality over the Profit, Brand over theSpeed, Social Value over the Corporate Value”, and guided by the development strategy of “Product Leadership, Operational Excellence, Global Vision”,the Company dedicates itself to providing safe, high-quality, cost-effective products and services with a strong user experience for customers worldwide.

Section III Management Discussion and Analysis

Section III Management Discussion and Analysis

(II) Main products and applicationsThe Company’s products in the medical segment include traditional wound care and bandaging, advanced wound dressings, operating room consumables,infection prevention, healthcare & personal care, and other products. The products in the consumer segment include dry and wet cotton tissues, sanitarynapkins, other non-woven products, baby and child apparel and products, adult apparel, and other woven products.

Main ApplicationsApplied in wound exudate absorbing, wounddressing, and sports protection

Specic Products

Medical cotton, gauze, bandage

Main Applications

Applied in occupational protection for medicalpersonnel and patient isolation

Specic Products

Face masks, protective clothing, isolation gowns,gloves, shoe covers, caps, etc.

Infection prevention

Healthcare & personalcare

Other products

Section III Management Discussion and Analysis

Specic Products

Cotton tissues, wet wipes, etc.

Specic Products

Baby and children’s sleepwear, outerwear,underwear, bath towels, handkerchiefs, swaddles,etc.

Dry and wet cotton tissues

Sanitary napkins

Other non-wovenproductsBaby and child apparel andproducts

Baby and child apparel andproducts

Adult apparel

The main product categories and illustrations of some products in the Company’s consumer segment are shown below:

Other woven products

Section III Management Discussion and Analysis

Section III Management Discussion and Analysis

Winner MedicalMedical consumables

PurcottonConsumer goods

Section III Management Discussion and Analysis

Section III Management Discussion and Analysis

Section III Management Discussion and Analysis

Section III Management Discussion and Analysis

Section III Management Discussion and Analysis

Section III Management Discussion and Analysis

(II) YoY changes in key financial data

Unit: RMB

Operating revenue

Operating cost

Selling expenses

Administrative expenses

Finance expenses

Income tax expenses

R&D expenses

Net cash ows from operatingactivities

Net cash ows from investingactivities

Net cash ows from nancing activities

Net increase in cash and cashequivalents

Significant changes in the profit composition or profit source of the Company during the reporting period

□Applicable √N/A

There was no significant change occurred in the profit composition or profit source of the Company during the reporting period.

Section III Management Discussion and Analysis

Products or services accounting for more than 10%

√Applicable □N/A

Unit: RMB

By products or services

By sector

Medical consumables

Consumer goods

By product

Medical consumables – traditionalwound care and bandaging

Medical consumables – operatingroom consumables

Consumer goods – dry and wetcotton tissues

Consumer goods – sanitary napkins

By region

Domestic

Overseas

Section III Management Discussion and Analysis

The Company is subject to the disclosure requirements for “Textile and Apparel Related Business” in the Shenzhen Stock Exchange Listed CompanySelf-Regulation Guidelines No. 3 – Industry Information Disclosure.

Unit: RMB

By sector

Consumer goods

By product

Consumer goods – dry and wetcotton tissues

Consumer goods – sanitarynapkins

Consumer goods – other non-woven products

Consumer goods – baby and childapparel and products

Consumer goods – adult apparel

Consumer goods – other wovenproducts

In cases where the statistical criteria for the Company’s main business data has been revised during the Reporting Period, the Company’s main businessfigures for the most recent one-year period, restated in accordance with the criteria applied as of the end of the Reporting Period

□Applicable √N/A

Section III Management Discussion and Analysis

Does the Company have physical store sales terminals?

√Yes □No

Physical store distribution

Directly operated

Franchised

Note: During the reporting period, certain stores were converted between direct-operated and franchised formats. These conversions are not counted as new openings or closures, and thestore opening figures have been adjusted accordingly.Total area of directly-operated stores and store efficiency

Less than 300 square meters

300-500 square meters

500-800 square meters

More than 800 square meters

Total

Explanation: The above data is for a year-over-year comparison of Purcotton stores that have been open for more than 12 months as of 30 June 2025.The top five stores in terms of operating revenue

Total

Section III Management Discussion and Analysis

New stores of listed companies

√Yes □No

Purcotton directlyoperated store

Purcotton directlyoperated store

Purcotton directlyoperated store

Purcotton directlyoperated store

Purcotton directlyoperated store

Purcotton franchisedstore

Purcotton franchisedstore

Purcotton franchisedstore

Purcotton franchisedstore

Total

Does the Company disclose information about its top five franchised stores?

□Yes √No

Section III Management Discussion and Analysis

IV. Other Information Required by the Industry Information Disclosure Guidelines for Textileand Apparel-Related Sectors

1. Capacity

Self-owned capacityCapacity utilization changed by more than 10% year on year

√Yes □No

Consumergoods

Is there overseas capacity?

□Yes √No

2. Sales model and channel

Sales channels and actual operation methods of the productsCompanies involved in textiles and apparel are in the consumer goods sector. The main sales channels for the consumer goods sector include online salesand physical stores.

Unit: RMB

Online sales

Physical store

Reason for change

Section III Management Discussion and Analysis

3. Selling expenses and composition

Unit: RMB

Employee benefits

Travel expenses

Office communication expenses

Sales commissions and chargesby E-commerce platform

Depreciation and amortisation

Advertising and promotionexpenses

Lease and property managementfees

Others

Total

4. Franchise and distribution

Franchisees and distributors achieved a sales revenue as a percentage over 30%

□Yes √No

Top five franchisees

Total

Top five distributors

Section III Management Discussion and Analysis

5. Online sales

Online sales achieved a revenue as a percentage over 30%

√Yes □No

The Company’s primary operation model involves setting up online stores on third-party e-commerce platforms such as Tmall, JD.com, and Douyin tosell products directly to end consumers. Under the direct sales model of e-commerce, the goods are delivered and control is transferred to the consumer.The revenue is recognized when the consumer confirms receipt of the goods.Were self-owned sales platforms built?

√Yes □No

Number of registered users

Average number of monthly active users

Was there cooperation with third-party sales platforms?

√Yes □No

Unit: RMB

Consumer goods sold at Taobao/Tmall

Opening or closing of online sales channels by the Company

□Applicable √N/A

Explain the impact on the Company’s current and future development

6. Outsourced operation model

Does it involve an outsourced operation model?

□Yes √No

Section III Management Discussion and Analysis

7. Inventory

Inventory

Raw materials and materialsconsigned for processing

Work in process

Goods on hand

Goods in transit

Low-value consumables

Total

Provision for inventory decline

Unit: RMB

Raw materials and materialsconsigned for processing

Work in process

Goods on hand

Goods in transit

Low-value consumables

Total

Inventory information of terminal channels such as franchisees or distributorsPurcotton has 104 franchised stores in operation. The business model for the franchised stores is that the franchisees are responsible for the constructionand daily operation of the stores, while Purcotton provides goods, training, and supply chain support. Revenues generated from franchised stores sales areshared between Purcotton and the franchisees. Purcotton retains ownership of inventory held in franchised stores. As of 30 June 2025, the inventorybalance was RMB42.87 million, averaging RMB410,000 per store.

Section III Management Discussion and Analysis

8. Brand building

Does the Company engage in the production and sale of branded garments, apparel, and home textile products?

√Yes □No

Proprietary brand

Purcotton

Purcotton

Purcotton

Purcotton

Purcotton

Purcotton

Purcotton

Section III Management Discussion and Analysis

Partner brands

Authorized brand

Marketing and operations of each brand during the Reporting PeriodFor detailed information, please refer to “III. Analysis of Main Business” in Section III, Management Discussion and Analysis.Disputes related to trademark ownership

□Applicable √N/A

9. Others

Does the Company engage in apparel design-related business?

√Yes □No

Operation of established designer platform

Does the Company hold order meetings?

□Yes √No

Section III Management Discussion and Analysis

V. Non-Core Business Activities

√Applicable □N/A

Unit: RMB

Investment income

Gains and losses fromchanges in fair value

Asset impairment

Non-operating revenue

Non-operating expense

Credit impairment loss

Gains on disposal ofassets

Other revenue

Section III Management Discussion and Analysis

VI. Analysis of Assets and Liabilities

1. Signicant changes in asset composition

Unit: RMB

Prepayments

2. Major Overseas Assets

□Applicable √N/A

Section III Management Discussion and Analysis

3. Assets and liabilities measured at fair value

√Applicable □N/A

Unit: RMB

Financial assets

1. Trading financial assets

(excluding derivativefinancial assets)

2. Other non-current

financial assets

Subtotal of financial assets

Total of the above

Financial liabilities

Other changesOthers primarily due to the exchange rate fluctuationsHas there been any significant change in the measurement attributes of the Company’s major assets during the Reporting Period?

□Yes √No

4. Restrictions on asset rights as of the end of the Reporting Period

For details, please refer to Section VIII Financial Report – VII. Notes to Items in the Consolidated Financial Statements – 31. Assets with restrictedownership or use rights.

VII. Investment Analysis

1. Overall situation

√Applicable □N/A

456,139,517.21

Note: Primarily due to a decrease in purchases of wealth management products during the period.

2. Signicant equity investments acquired during the Reporting Period

□Applicable √N/A

Section III Management Discussion and Analysis

3. Signicant non-equity investments in progress during the Reporting Period

□Applicable √N/A

4. Financial Assets Measured at Fair Value

√Applicable □N/A

Unit: RMB

Others

Trustproducts

Total

Note 1: For other asset categories, the gains and losses from changes in fair value for the current period are negative, mainly because the income fromwealth management products due for this period has been reclassified to the investment income account.Note 2: Trust products primarily consist of risk-rated R2/R3 products and do not involve investments in stocks and real estate.

5. Use of raised funds

□Applicable √N/A

The Company does not use any raised funds during the reporting period.

6. Entrusted financial management, derivatives investment and entrusted loans

(1) Information of entrusted financial management

√Applicable □N/A

Overview of entrusted financial management during the reporting period

Unit: ’0,000 yuan

Wealth managementproducts issued bybanks

Trust financialproducts

Total

Note: The amount of entrusted wealth management for trust products here is the balance of unexpired wealth management products.

Specific circumstance of high-risk entrusted financing with significant single amount or with low security and poor liquidity

□Applicable √N/A

The entrusted financing is expected not to recover the principal or has other circumstances that may cause impairment

□Applicable √N/A

Section III Management Discussion and Analysis

(2) Derivatives investment

□Applicable √N/A

No derivative investment in the Company during the reporting period

(3) Information of entrusted loans

□Applicable √N/A

The Company had no entrusted loan during the reporting period.

VIII. Disposal of Major Assets and Equity

1. Disposal of major assets

□Applicable √N/A

The Company had no disposal of major assets during the Reporting Period.

2. Disposal of major equity

□Applicable √N/A

IX. Analysis of Principal Subsidiaries and Affiliates

√Applicable □N/A

Information on major subsidiaries and affiliates contributing over 10% to the Company’s net profit

Unit: RMB

WinnerMedical(Huanggang) Co., Ltd.

Acquisition and disposal of subsidiaries during the Reporting Period

□Applicable √N/A

Explanation of principal subsidiaries and affiliates

Section III Management Discussion and Analysis

X. Structured Entities Controlled by the Company

□Applicable √N/A

XI. Risks Faced by the Company and Countermeasures

1. Risk of changes in industry policies and standards

The medical device industry, due to its direct connection to human health and safety, is subject to stringent government oversight. In recent years, withthe continuous deepening of reforms in the pharmaceutical and healthcare systems, relevant government departments have introduced a series ofregulations and policies in areas such as industry standards, bidding rules, pricing mechanisms, and distribution systems. The implementation of thesepolicies has had a broad and profound impact on the development of the medical device industry. Should the Company fail to adapt swiftly to thesepolicy changes, it could face operational challenges. As a result, the Company remains vigilant of regulatory developments and actively adjusts itsstrategy to ensure both compliance and market competitiveness.

2. Risk of raw material price fluctuations and countermeasures

The Company’s core raw materials consist primarily of cotton and cotton-derived products, including cotton yarn and medical greige fabrics. Cottonprices are subject to a wide array of influencing factors, such as acreage under cultivation, climate conditions, inventory cycles, government pricingpolicies, market demand, futures market dynamics, international trade regulations, and currency exchange rate fluctuations. Should raw material costscontinue to rise while product pricing fails to adjust in parallel, the resulting inability to pass on costs may exert pressure on profit margins and adverselyaffect the Company’s profitability. To mitigate this risk, the Company has implemented a proactive cotton procurement strategy. This includes increasingstrategic inventory when prices are low, and deploying a price linkage mechanism during high-price periods to adjust retail pricing and optimize discountpolicies. In parallel, the Company opportunistically invests in cotton derivatives as a hedging tool to manage price volatility, thereby reducing itspotential impact on financial performance.

3. Risk from shifts in the international trade environment

Currently, the global trade landscape remains volatile and complex, shaped by geopolitical tensions, rising tariff barriers, policy adjustments affectingimports and exports, and fluctuations in international logistics costs. These dynamics present growing challenges and operational costs for the Company’soverseas business, particularly with regard to the U.S. market. For the medical consumables segment, divergent regulatory standards across jurisdictionscan result in burdensome product certification and market entry requirements, increasing both operational complexity and time-to-market. Failure toadapt swiftly to such changes may lead to order reductions, higher costs, and delayed deliveries. As of the end of the Reporting Period, the Company’sconsumer goods segment does not involve sales to the United States. Its medical sector exports are concentrated in Europe and Japan, with only a limitedshare attributable to the U.S. market. In addition, the Company’s subsidiary GRI maintains production capacity in the U.S., which helps partially offsetrelated risks. Going forward, the Company will closely monitor global trade developments, adjust its market deployment strategies with agility, andenhance supply chain resilience to minimize the potential operational impact of external uncertainties.

4. Risk of exchange rate uctuations and countermeasures

The Company’s cross-border transactions are settled primarily in U.S. dollars and other major foreign currencies, notably involving the export of medicalconsumables and the international procurement of cotton. Exchange rate fluctuations have a dual impact – affecting both the competitiveness of productpricing in overseas markets and the cost structure of imported raw materials, as well as creating potential foreign exchange gains or losses. A substantialappreciation of the Renminbi could erode the Company’s pricing power abroad and result in negative currency translation effects, adversely impactingfinancial performance. To counter this, the Company has established a multi-tiered hedging framework. Key measures include: incorporating exchangerate adjustment clauses in contracts with long-term clients; shortening quotation cycles for new orders to improve responsiveness to currency fluctuations;executing forward foreign exchange contracts for hedging purposes, thereby locking in future settlement rates, and enhancing its foreign exchangemonitoring and analytical capabilities to track currency market trends in real time and mitigate the impact of exchange rate volatility on profitability.

Section III Management Discussion and Analysis

5. Competition risks in the consumer goods business

Each segment of the Company’s consumer goods business operates in highly competitive markets, facing rivals from both established domestic andinternational brands, as well as new entrants. Competitors may engage in price wars, increase marketing spend, launch innovative products, or expanddistribution channels to capture market share. Such actions could put pressure on the Company’s market share, slow revenue growth, and compress profitmargins. Rapid shifts in consumer preferences also pose risks if emerging trends are not promptly identified or if product development and innovationfail to keep pace. To mitigate these risks, the Company maintains a stable management team and efficient decision-making processes. It regularlydevelops rigorous business plans, closely monitors market trends, drives continuous R&D innovation, and consistently upholds its principles of productleadership and operational excellence to meet consumer needs and strengthen brand recognition.

6. Risks of cross-border acquisitions

During the Reporting Period, the Company successfully completed the acquisition projects of overseas equity, accelerating Winner Group’s globalexpansion. However, this also introduces various risks, including: fluctuations in international political and economic conditions; changes in the targetcountry’s policies and regulations (such as legal systems, tariff policies, labor policies, and regulatory frameworks); exchange rate volatility; differencesin cultures and business practices; and challenges related to the integration of management systems, personnel coordination, and technology transfer.These risks may hinder the integration process, result in lower-than-expected business synergies, and negatively impact the Company’s financialcondition and operating results. To mitigate these risks, the Company will enhance communication and exchange with the acquired companies, deepenunderstanding of local culture, market environment, and regulatory systems, rigorously implement integration plans, continuously improve its riskassessment mechanisms, and strengthen compliance management and training to reduce the risks of cross-border acquisitions.

7. Risk of goodwill impairment and countermeasures

To build a one-stop solution for medical consumables, Winner Medical has, in recent years, executed a series of strategic acquisitions to extend andstrengthen its industrial value chain. As a result, a material amount of goodwill has accumulated. In accordance with accounting standards, goodwill mustundergo annual impairment testing at the end of each fiscal year. If the operational performance of an acquired entity fails to meet expectations, agoodwill impairment may be triggered – resulting in a direct hit to current-period earnings and potentially impacting shareholder equity and marketvaluation. To address this risk, the Company has further enhanced its postacquisition management system. Through strategic business integration,resource consolidation, and targeted management incentives, the Company aims to improve the operational performance of acquired entities.Additionally, the Company exercises prudence in evaluating the valuation rationale of new acquisition targets, striving to minimize the risk of goodwillimpairment and its downstream effects on financial statements.

8. Risk of inability to recover the remaining compensation from the Winner investment project inHeyuan and countermeasuresDue to planning adjustments to the Heyuan Station forecourt and the High-Speed Rail New Town associated with the Ganzhou-Shenzhen high-speedrailway, the Agreement on the Investment and Construction of Medical Kit and Cotton-Based Daily Necessities Production Project signed between theCompany and the People’s Government of Zijin County, Heyuan City in 2016 could not be executed. In November 2019, the Ganjiang New AreaInternational Arbitration Court ruled to terminate the agreement, ordering the Zijin County Government to compensate the Company in the amount ofRMB550 million, payable in two installments by 31 December 2019, and 29 February 2020 respectively. As of the end of the Reporting Period, theCompany had received a refund of RMB3 million for the land transfer deposit and RMB330 million in compensation. However, the remaining balance ofapproximately RMB217 million is at risk of nonrecovery. Out of prudence, the Company has made a bad debt provision of RMB110 million for theoutstanding amount. The Company is actively maintaining communication with the local government and continues to pursue the recovery of theremaining compensation.

Section III Management Discussion and Analysis

XII. Record of Investor Relations Activities Including Research Visits, Communications, andInterviews during the Reporting Period

√Applicable □N/A

17 January 2025

19 February 2025

07 May 2025

28 May 2025

24 June 2025

XIII. Establishment and Implementation of Market Capitalization Management Systems andValuation Enhancement PlansHas the Company established a market capitalization management system?

√Yes □No

Has the Company disclosed a valuation enhancement plan?

□Yes √No

For the further standardization of its market capitalization management practices, the Company has formulated the Market Capitalization ManagementSystem of Winner Medical Co., Ltd. to promote the enhancement of investment value, increase investor returns, and protect the legitimate rights andinterests of the Company, investors, and other stakeholders. This system was developed in accordance with the relevant provisions of the Company Law,Securities Law, Opinions of the State Council on Strengthening Supervision to Prevent Risks and Promote High-Quality Development of the CapitalMarket, the Measures for the Administration of Information Disclosure by Listed Companies, and Guideline on the Supervision of Listed Companies No.10 – Market Capitalization Management, and was reviewed and approved by the Board of Directors.

Section III Management Discussion and Analysis

XIV. Implementation of the “Dual Improvement of Quality and Return” Action PlanHas the Company disclosed the “Dual Improvement of Quality and Return” action plan announcement?

√Yes □No

Guided by the principles of “activating the capital market and boosting investor confidence” and “significantly improving the quality and investmentvalue of listed companies through more effective measures to stabilize the market and confidence”, the plan aligns with the Company’s developmentstrategy, operational realities, and financial position.As a health enterprise integrating medical and consumer sectors, the Company upholds the vision of “Caring Health, Cherishing Life, and Protecting theEnvironment for A Better World”. It operates two major brands, Winner Medical and Purcotton, offering products spanning wound care, infectionprotection, operating room consumables, personal care, home care, maternal and infant care, home textiles, and apparel. Adhering to the core businessprinciples of “Quality over the Profit, Brand over the Speed, Social Value over the Corporate Value”, and guided by the development strategy of“Product Leadership, Operational Excellence, Global Vision”, the Company dedicates itself to providing safe, high-quality, cost-effective products andservices with a strong user experience for customers worldwide.The Company continues to optimize its corporate governance structure, strengthen internal controls, enhance risk management, and lay a solid foundationfor high-quality, sustainable development. The Company has been honored with the Best Board Practices award by the China Listed CompaniesAssociation for three consecutive years. It has voluntarily published corporate social responsibility (CSR) and ESG reports for five consecutive years andhas been recognized as an ESG Best Practice Case of Listed Companies by the same association for four consecutive years. As a participant in the UnitedNations Global Compact, the Company actively implements sustainable development strategies and was awarded the UN Global Compact China BestPractice Case in 2021.The Company strictly adheres to information disclosure requirements under securities laws and regulations, proactively develops investor engagementplatforms, and continuously enhances the breadth, depth, and timeliness of its disclosures. It has been selected for inclusion in the Shenzhen StockExchange Growth Enterprise Market Annual Report Outstanding Case Compilation for two consecutive years and has maintained an “A” rating in annualinformation disclosure assessments since listing.Consistently prioritizing investors, the Company focuses on improving core business efficiency while rigorously implementing profit distribution policies.Since its 2020 listing, it has issued six cash dividends totaling RMB2.613 billion, with the 2025 interim dividend pending (dividend amount: RMB262million), and conducted two share repurchases totaling RMB695 million. The combined total of dividends and share repurchases is RMB3.57 billion,representing 100.33% of net proceeds from the initial public offering.

Section IV Corporate Governance, Environmental and Social

Responsibilities

Section IV

CorporateGovernance,Environmentaland SocialResponsibilities

Section IV Corporate Governance, Environmental and SocialResponsibilities

I. Change of Directors, Supervisors and Senior Management

□Applicable √N/A

There were no changes in the directors, supervisors and senior management of the Company during the reporting period, which can be found in theAnnual Report 2024.II. Profit Distribution and Share Capital Increase from Capital Surplus in the Reporting Period

√Applicable □N/A

Amount of dividend to be distributed per 10 shares held (RMB) (tax inclusive)

Base of share capital for the distribution plan (shares)

Amount of cash dividend (RMB) (tax inclusive)

Amount of cash dividend in other forms (e.g. share repurchase) (RMB)

Total amount of cash dividend (including in other forms) (RMB)

Profit available for distribution (RMB)

Percentage of total amount of cash dividend (including in other forms) in the total amount ofprofit distributed

Current Cash Dividend

Current Cash DividendOthers

Detailed explanation on prot distribution plan and the proposal on share capital increase from capital surplus

Detailed explanation on prot distribution plan and the proposal on share capital increase from capital surplus

The Company’s profit distribution plan for 2025 is as follows: based on the current total share capital of 582,329,808 shares, a cash dividend of RMB4.50(tax inclusive) will be distributed for every 10 shares held by shareholders, totaling RMB262,048,413.60 (tax inclusive) to be distributed. No sharecapital increase from capital surplus, and no distribution of bonus shares. The proportion of cash dividends for the first half of 2025 to the net profitattributable to shareholders of the listed company is 53.26%.During the period from the disclosure to the implementation of the profit distribution plan, if the total amount of shares enjoying the right to profitdistribution changes, the company will make corresponding adjustments in accordance with the principle that the cash dividend ratio remains unchangedwhile the total amount of cash dividends changes.The company's 2024 annual shareholders' meeting has authorized the board of directors to, under the premise of meeting the profit distributionrequirements, comprehensively consider the company's operating conditions, reasonable returns to shareholders, etc., to formulate the specific plan forthe interim profit distribution in 2025 and handle the related matters of the interim profit distribution.

The Company’s profit distribution plan for 2025 is as follows: based on the current total share capital of 582,329,808 shares, a cash dividend of RMB4.50(tax inclusive) will be distributed for every 10 shares held by shareholders, totaling RMB262,048,413.60 (tax inclusive) to be distributed. No sharecapital increase from capital surplus, and no distribution of bonus shares. The proportion of cash dividends for the first half of 2025 to the net profitattributable to shareholders of the listed company is 53.26%.During the period from the disclosure to the implementation of the profit distribution plan, if the total amount of shares enjoying the right to profitdistribution changes, the company will make corresponding adjustments in accordance with the principle that the cash dividend ratio remains unchangedwhile the total amount of cash dividends changes.The company's 2024 annual shareholders' meeting has authorized the board of directors to, under the premise of meeting the profit distributionrequirements, comprehensively consider the company's operating conditions, reasonable returns to shareholders, etc., to formulate the specific plan forthe interim profit distribution in 2025 and handle the related matters of the interim profit distribution.

III. Implementation of the Company’s Equity Incentive Plan, Employee Stock Ownership Planor Other Employee Incentive Measures

√Applicable □N/A

1. Equity incentive

On 25 October 2024, the Company held the Fourth Meeting of the Fourth Board of Directors and the Fourth Meeting of the Fourth Board of Supervisors.On 13 November 2024, it convened the 2024 Fourth Extraordinary General Meeting of Shareholders, during which the Proposal on the Company's 2024Restricted Stock Incentive Plan (Draft) and Its Summary and related matters were reviewed and approved.On 15 November 2024, the Company held the Fifth Meeting of the Fourth Board of Directors and the Fifth Meeting of the Fourth Board of Supervisors,approving the Proposal on the Initial Grant of Restricted Stock to Incentive Targets under the 2024 Restricted Stock Incentive Plan. The grant date wasset as 15 November 2024, with RMB6.9763 million restricted shares awarded to 308 eligible incentive recipients.

Section IV Corporate Governance, Environmental and Social

Responsibilities

2. Implementation of employee stock ownership plan

√Applicable □N/A

All effective employee stock ownership plans implemented during the Reporting Period

Core employees at director level(inclusive) or above

Shares held by Directors, Supervisors and senior management under the employee stock ownership plan during the Reporting Period

Liao Meizhen

Changes in asset management institutions during the Reporting Period

□Applicable √N/A

Changes in equity caused by holders’ disposal of shares during the Reporting Period

□Applicable √N/A

Exercise of shareholders’ rights during the Reporting Period N/AOther pertinent circumstances and explanations regarding employee stock ownership plan during the Reporting Period

√Applicable □N/A

During the Reporting Period, one participant in the employee stock ownership plan left the Company. In accordance with the First Phase Employee StockOwnership Plan Management Measures, the Management Committee calculated the vested portion based on the length of employment. The remainingunvested stock rights were repurchased by the Management Committee at the original investment cost. After the lock-up period, the repurchased stockrights will be sold at an appropriate time, with the proceeds accruing to the CompanyChanges in the membership of the Employee Stock Ownership Plan Management Committee

□Applicable √N/A

The financial impact of employee stock ownership plan on the listed company during the Reporting Period and the associated accounting treatment

√Applicable □N/A

Section IV Corporate Governance, Environmental and SocialResponsibilities

According to the provisions of Accounting Standards for Business Enterprises No. 11 – Share-based Payment, on each balance sheet date during thevesting period, the relevant costs or expenses and capital reserves are determined based on the best estimate of the number of exercisable equityinstruments and the fair value of the equity instrument on the grant date, reflecting the services obtained in the current period.Termination of employee stock ownership plan during the Reporting Period

□Applicable √N/A

Other descriptions:

None

3. Other employee incentive measures

□Applicable √N/A

IV. Environmental Information DisclosureWhether the listed Company and its major subsidiaries are included in the list of enterprises legally required to disclose environmental information

√Yes □No

Serialnumber

Section IV Corporate Governance, Environmental and Social

Responsibilities

The Company is subject to the disclosure requirements for “Textile and Apparel Related Business” in the Shenzhen Stock Exchange Listed CompanySelf-Regulation Guidelines No. 3 – Industry Information Disclosure.Information on environmental accidents of listed companiesNoneV. Performance of Social ResponsibilityGuided by the vision of "Caring Health, Cherishing Life, and Protecting the Environment for A Better World", the Company consistently upholds its corebusiness principles of "Quality over the Profit, Brand over the Speed, Social Value over the Corporate Value" across all aspects of its operations. Duringthe reporting period, the Company delivered support and care through diverse initiatives, demonstrating corporate social responsibility through concreteactions.(I) Rapid Disaster Relief, Protecting Hope in Times of CrisisFollowing the 6.8-magnitude earthquake in Dingri County, Shigatse City, Tibet, the Company responded immediately, partnering with the ChinaWomen’s Development Foundation and the Red Cross Society of Tibet Autonomous Region to donate supplies. Winner Medical contributed in medicalsupplies, including protective masks, heating products, disinfectants, and wound care products, providing crucial support for medical relief efforts in thedisaster area. Purcotton and Nice Princess provided winter supplies and daily necessities, including adult and children’s clothing, thermal underwear sets,cotton quilts, blankets, and Nice Princess sleep pants, helping to safeguard the livelihoods of affected residents.

(II) Actively Promoting Women’s Care Initiatives to Spread Mutual WarmthPurcotton’s sanitary napkin brand, Nice Princess, launched the “Nice For Her” public welfare campaign in Lantian, Shaanxi. During the event, Purcottondonated supplies to the China Women’s Development Foundation and distributed “menstrual care packages” containing sanitary napkins and educationalmaterials to female students, helping them develop scientific awareness of menstruation and navigate adolescence with confidence. The brand is alsoexpanding its long-term initiative to create more female-friendly spaces. Through partnerships with over 200 shopping malls and nearly 500 Purcottonstores nationwide, it provides free emergency sanitary products—delivering meaningful change for women’s everyday needs.

(III) Caring for Diverse Groups to Extend Warmth to Every Corner

1. Festive Public Welfare Empowerment: During International Women’s Day, the Company’s Party Committee organized the “Blooming Guardians”campaign, offering select Purcotton star products for public welfare pricing. This initiative raised donation to support women and children in need,delivering warmth and hope.

2. Health Education in Schools: During May’s Health Month, the “Party-Building Public Welfare Classes” reached 11 schools, including two specialeducation institutions, providing students and teachers with personal hygiene and wound care knowledge and fostering healthcare awareness amongchildren with special needs.

3. Targeted Assistance Warms Hearts: The Party Committee partnered with Longhua Charity Association and Longhua People’s Hospital for the “Party-Building Guards Health · Love Fills Longhua” initiative, donating professional nasal care products to support rhinitis patients and underprivilegedfamilies. The committee also collaborated with Shenzhen Express Delivery Industry Association’s Party Committee for the “Care for Delivery Riders”campaign, donating cooling vests to Yunda and JD teams.

Section V Important Matters

Section VImportantMatters

Section V Important Matters

I. Commitments Fullled within and not Fullled by the End of the Reporting Period by theCompany’s Actual Controller, Shareholders, Related Parties, Acquirer, the Company, andOther Committing Parties

□Applicable √N/A

No commitments fulfilled within and within and not fulfilled by the end of the reporting period by the Company’s actual controller, shareholders, relatedparties, acquirers and other commitment parties.II. Non-operating Occupation of Funds of the Listed Company by the Controlling Shareholderand Other Related Parties

□Applicable √N/A

There was no non-operating occupation of funds of the listed company by the controlling shareholder and other related parties during the ReportingPeriod.III. Illegal External Guarantee

□Applicable √N/A

The Company had no illegal external guarantee during the Reporting Period.IV. Appointment of and Dismissal of Accounting FirmsWhether the semi-annual financial report has been audited

□Yes √No

The semi-annual report of the Company has not been audited.V. Explanation by the Board of Directors, the Board of Supervisors and the Audit Committeeon the “Non-Standard Audit Report” Issued by the Accounting Firm for the Reporting Period

□Applicable √N/A

VI. Explanation by the Board of Directors on the “Non-standard Audit Report” of the PreviousYear

□Applicable √N/A

VII. Matters Related to Bankruptcy Reorganization

□Applicable √N/A

The Company had no matters related to bankruptcy reorganization during the Reporting Period.

Section V Important Matters

VIII. Litigation MattersMajor litigation and arbitration matters

□Applicable √N/A

The Company had no major litigation and arbitration matters in the year.Other litigation matters

□Applicable √N/A

IX. Punishment and Rectification

□Applicable √N/A

The Company had no punishment and rectification during the Reporting Period.X. Credit Status of the Company, Its Controlling Shareholders and Actual Controller

□Applicable √N/A

XI. Major Related-party Transactions

1. Related-party transactions related to daily operation

□Applicable √N/A

The Company had no related-party transactions related to daily operation during the Reporting Period.

2. Related-party transactions involving the acquisition or sale of assets or equity

□Applicable √N/A

The Company had no related-party transactions involving the acquisition or sale of assets or equity during the Reporting Period.

3. Related-party transactions involving joint external investment

□Applicable √N/A

The Company had no related-party transactions involving joint external investment during the Reporting Period.

4. Related-party receivables and payables

□Applicable √N/A

The Company had no related-party receivables and payables during the Reporting Period.

Section V Important Matters

5. Transactions with related nance companies

□Applicable √N/A

There was no deposit, loan, credit granting or other financial business between the Company and the finance company with which it is affiliated, thefinance company controlled by the Company and the related parties.

6. Transactions between the Company’s majority-owned nance companies and related parties

□Applicable √N/A

There was no deposit, loan, credit granting, or other financial business between the Company’s majority-owned finance companies and related parties.

7. Other major related-party transactions

□Applicable √N/A

The Company had no other major related-party transactions during the Reporting Period.XII. Major Contracts and Their Performance

1. Trusteeship, contracting and lease

(1) Trusteeship

□Applicable √N/A

The Company had no trusteeship during the Reporting Period.

(2) Contracting

□Applicable √N/A

The Company had no contracting during the Reporting Period.

(3) Lease

□Applicable √N/A

The Company had no lease during the Reporting Period.

2. Major guarantee

□Applicable √N/A

The Company had no major guarantee during the Reporting Period.

3. Major contracts for daily operation

□Applicable √N/A

Section V Important Matters

4. Other major contracts

□Applicable √N/A

The Company had no other major contracts during the Reporting Period.XIII. Explanation on Other Signicant Events

√Applicable □N/A

In July 2023, the Company entered into a relocation compensation and resettlement agreement with Shenzhen Xingda Real Estate Development Co., Ltd.(hereafter referred to as "Xingda") for the urban renewal involving the land and above-ground buildings in the Winner Industrial Park in Longhua District,Shenzhen, which the Company holds. Due to the significant changes in the real estate market, the project was put on hold in January 2024. To smoothlyadvance the project, shorten the land idle time, and reduce uncertainties in the construction process, and in light of the market conditions for relocationcompensation for urban renewal, the Company conducted multiple rounds of negotiations with its partner, and signed a supplementary agreement onAugust 19, 2024. According to the proposed supplementary agreement, the area of office space and commercial space obtained by the Company remainsunchanged, while the area of residential space and the amount of compensation obtained by the Company will be linked to the actual average transactionprice of the residential units obtained by Xingda Company. There is uncertainty in the area of residential space and the amount of indemnity obtained bythe Company given the significant fluctuations in the real estate market. Currently, Xingda has obtained the implementation entity confirmation letter forthis project and is proceeding with building demolition.This project is subject to factors including urban renewal policy adjustments, urban planning changes, counterparty performance capabilities, marketconditions, pricing, and force majeure, and has a relatively long execution period. The Company will actively promote the project, strengthencommunication and process control, and strive to reduce uncertainties in the execution process.XIV. Signicant Events of Subsidiaries

□Applicable √N/A

Section VI Changes in Shares and Information on Shareholders

Section VIChanges inShares andInformation onShareholders

Section VI Changes in Shares and Information on Shareholders

I. Changes in Shares

1. Changes in shares

Unit: share

I. Shares with selling restrictions

1. State-owned shares

2. Shares held by state-owned

legal persons

3. Other shares held by domestic

individuals and legal persons

Including: shares held bydomestic legal persons

Shares held by domestic naturalpersons

4. Shares held by overseas

individuals and legal persons

Including: shares held by overseaslegal persons

Shares held by overseas naturalpersons

II. Shares without sellingrestrictions

1. RMB ordinary shares

2. Domestically listed foreign

shares

3. Overseas listed foreign shares

4. Others

III. Total number of shares

Reasons for changes in shares

√Applicable □N/A

Shareholdings of Directors, Supervisors, and senior management are subject to lock-up periods, release of restrictions on sale in compliance withrequirements of China Securities Regulatory Commission. Details are provided in “2. Changes in Restricted Shares” within this section.Approval on changes in shares

□Applicable √N/A

Transfer due to changes in shares

□Applicable √N/A

Section VI Changes in Shares and Information on Shareholders

Progress of share repurchase implementation

□Applicable √N/A

Progress of reduction of repurchased shares via centralized bidding transactions

□Applicable √N/A

The impact of changes in shares on nancial indicators, such as basic earnings per share, diluted earnings per share, and net assets per share attributable toordinary shareholders of the Company for the latest year and the latest period

□Applicable √N/A

Other information deemed necessary by the Company or required by securities regulatory authorities to disclose

□Applicable √N/A

2. Changes in restricted shares

√Applicable □N/A

Unit: share

WinnerGroupLimited

FangXiuyuan

Zhang Yan

ChenHuixuan

Liu Hua

Xu Xiaodan

Zhang Li

Wang Ying

Total

II. Securities Issuance and Listing

□Applicable √N/A

Section VI Changes in Shares and Information on Shareholders

III. Number of Shareholders and Their Shareholding

Unit: share

Shareholding information of shareholders holding 5% or more, or the top 10 shareholders (excluding shares lent through margin nancing and securities lending)

Shareholding information of shareholders holding 5% or more, or the top 10 shareholders (excluding shares lent through margin nancing and securities lending)Name of shareholder

Winner Group Limited

Bank of China Limited - Huabao CSIHealthcare ETF

Industrial and Commercial Bank of ChinaLimited – E Fund ChiNext ETF

Hong Kong Securities Clearing CompanyLimited

Xiamen Leyuan Investment Partnership(Limited Partnership)

Agricultural Bank of China Limited – CSI 500ETF

Guoshou Asset Management – China LifeInsurance Company Limited – ParticipatingPolicy – Guoshou Asset Management ChinaLife Balanced Equity Portfolio Single AssetManagement Plan (Available-for-Sale)

China Life Insurance Company Limited –Traditional – Ordinary Insurance Products –005L – CT001 Shanghai

Agricultural Bank of China Limited – BOCOMSchroders Fund Domestic Demand GrowthOne-Year Holding Mixed SecuritiesInvestment Fund

China CITIC Bank Corporation Limited –BOCOM Schroders Fund Quality Growth One-Year Holding Mixed Securities InvestmentFund

Strategic investors or general legal persons become top 10 shareholdersdue to the allotment of new shares (if any) (see note 3)

Explanation of the related party relationships orconcerted actions among the above-mentionedshareholders

Explanation of the delegation/trust of voting rights or waiver of votingrights among the above-mentioned shareholders

Special note on the repurchase account amongthe top 10 shareholders (see Note 11)

Section VI Changes in Shares and Information on Shareholders

Shareholding information of the top 10 shareholders of shares without selling restriction (excluding shares lent through margin nancing and securities lending, and lock-up shares held by

senior management)Name of shareholder

Bank of China Limited - Huabao CSI Healthcare ETF

Industrial and Commercial Bank of China Limited – E Fund ChiNext ETF

Hong Kong Securities Clearing Company Limited

Xiamen Leyuan Investment Partnership (Limited Partnership)

Agricultural Bank of China Limited – CSI 500 ETF

Guoshou Asset Management – China Life Insurance Company Limited –Participating Policy – Guoshou Asset Management China Life BalancedEquity Portfolio Single Asset Management Plan (Available-for-Sale)

China Life Insurance Company Limited – Traditional – OrdinaryInsurance Products – 005L – CT001 Shanghai

Agricultural Bank of China Limited – BOCOM Schroders Fund DomesticDemand Growth One-Year Holding Mixed Securities Investment Fund

China CITIC Bank Corporation Limited – BOCOM Schroders FundQuality Growth One-Year Holding Mixed Securities Investment Fund

China Merchants Bank Co., Ltd. – Dongfanghong Ruize Three-YearHolding Mixed Securities Investment Fund

Explanation of the related party relationships or concerted actions betweenthe top 10 shareholders of outstanding shares without selling restriction,and between the top 10 shareholders of outstanding shares without sellingrestriction and the top 10 shareholders

Information on the top 10 shareholders involved in margin trading andsecurities lending

Shares lent through margin financing and securities lending by shareholders holding 5% or more shares, the top 10 shareholders and top 10 holders ofoutstanding shares without selling restriction

□Applicable √N/A

Changes in the top 10 shareholders and top 10 holders of outstanding shares without selling restriction as caused by margin financing and securitieslending and returning activities

□Applicable √N/A

Has the Company a differentiated voting rights structure

□Yes √No

Section VI Changes in Shares and Information on Shareholders

Whether the top 10 ordinary shareholders and the top 10 holders of ordinary shares without selling restriction conducted agreed repurchase transactionsduring the Reporting Period

□Yes √No

The top 10 ordinary shareholders and the top 10 holders of ordinary shares without selling restriction did not conduct agreed repurchase transactionsduring the Reporting Period.

IV. Equity Changes of Directors, Supervisors and Senior Management

□Applicable √N/A

There were no changes in the shareholdings of the Company’s directors, supervisors, or senior management during the reporting period. For details,please refer to the 2024 Annual Report.V. Change in Controlling Shareholders or Actual Controllers

Change of controlling shareholders during the reporting period

□Applicable √N/A

The Company had no change in controlling shareholders during the reporting period. Changes in actual controller during the reporting period

□Applicable √N/A

The Company had no change in actual controller during the reporting period.

VI. Preference Shares

□Applicable √N/A

The Company had no preference shares during the Reporting Period.

Section VII Bonds

Section VIIBonds

□Applicable √N/A

Section VIIIFinancial Report

I. Auditor’s ReportWhether the semi-annual report is audited

□Yes √No

The Company's semi-annual financial statement has not been audited.

II. Financial StatementsThe notes to financial statements are expressed in Renminbi Yuan.

1. Consolidated balance sheet

Preparer: Winner Medical Co., Ltd.

30 June 2025

Unit: RMB

Current assets:

Currency fund

Settlement reserves

Placements to banks and other financial institutions

Trading financial assets

Derivative financial assets

Notes receivable

Accounts receivable

Receivables financing

Prepayments

Premium receivable

Reinsurance receivables

Due from Reinsurer for reserve of reinsurancecontract

Other receivables

Including: Interest receivable

Dividends receivable

Financial assets held under resale agreements

Inventories

Including: Data resources

Contract assets

Financial assets held for trading

Current portion of non-current assets

Other current assets

Total current assets

Non-current assets:

Loans and advances to customers

Debt investments

Other debt investments

Long-term receivables

Long-term equity investments

Other equity investments

Other non-current financial assets

Investment properties

Fixed assets

Construction in progress

Productive biological assets

Oil and gas assets

Right-of-use assets

Intangible assets

Including: Data resources

Development expenditures

Including: Data resources

Goodwill

Long-term prepaid expenses

Deferred tax assets

Other non-current assets

Total non-current assets

Total assets

Current liabilities:

Short-term borrowings

Borrowings from the Central Bank

Placements from banks and other financialinstitutions

Trading financial liabilities

Derivative financial liabilities

Notes payable

Accounts payable

Receipts in advance

Contract liabilities

Financial assets sold under repurchase agreements

Customer deposits and deposits from banks and otherfinancial institutions

Customer money for securities trading

Proceeds from securities underwriting on agencybasis

Employee benefits payable

Taxes and surcharges payable

Other payables

Including: Interest payable

Dividends payable

Fees and commissions payable

Reinsurance payables

Liabilities classified as held for sale

Non-current liabilities due within one year

Other current liabilities

Total current liabilities

Non-current liabilities:

Reserves for insurance Contract

Long-term borrowings

Bonds payable

Including: Preference shares

Perpetual bonds

Lease liabilities

Long-term payables

Long-term employee benefits payable

Provisions

Deferred income

Deferred tax liabilities

Other non-current liabilities

Total non-current liabilities

Total liabilities

Owner's equity:

Share capital

Other equity investments

Including: Preference shares

Perpetual bonds

Capital reserves

Less: Treasury shares

Other comprehensive income

Specialised reserves

Surplus reserves

General reserve

Unappropriated profit

Total equity attributable to owners of the parent

Non-controlling interests

Total equity

Total liabilities and equity

Legal representative: Li Jianquan

2. Parent company’s balance sheet

Unit: RMB

Current assets:

Currency fund

Trading financial assets

Derivative financial assets

Notes receivable

Accounts receivable

Receivables financing

Prepayments

Other receivables

Including: Interest receivable

Dividends receivable

Inventories

Including: Data resources

Contract assets

Financial assets held for trading

Current portion of non-current assets

Other current assets

Total current assets

Non-current assets:

Debt investments

Other debt investments

Long-term receivables

Long-term equity investments

Other equity investments

Other non-current financial assets

Investment properties

Fixed assets

Construction in progress

Productive biological assets

Oil and gas assets

Right-of-use assets

Intangible assets

Including: Data resources

Development expenditures

Including: Data resources

Goodwill

Long-term prepaid expenses

Deferred tax assets

Other non-current assets

Total non-current assets

Total assets

Current liabilities:

Short-term borrowings

Trading financial liabilities

Derivative financial liabilities

Notes payable

Accounts payable

Receipts in advance

Contract liabilities

Employee benefits payable

Taxes and surcharges payable

Other payables

Including: Interest payable

Dividends payable

Liabilities classified as held for sale

Non-current liabilities due within one year

Other current liabilities

Total current liabilities

Non-current liabilities:

Long-term borrowings

Bonds payable

Including: Preference shares

Perpetual bonds

Lease liabilities

Long-term payables

Long-term employee benefits payable

Provisions

Deferred income

Deferred tax liabilities

Other non-current liabilities

Total non-current liabilities

Total liabilities

Owner's equity:

Share capital

Other equity investments

Including: Preference shares

Perpetual bonds

Capital reserves

Less: Treasury shares

Other comprehensive income

Specialised reserves

Surplus reserves

Unappropriated profit

Total equity

Total liabilities and equity

Legal representative: Li Jianquan

3. Consolidated income statement

Unit: RMB

I. Total Revenue

Including: Revenue

Interest income

Premium earned

Fee and commission income

II. Total Costs

Including: Cost of sales

Interest expenses

Fee and commission expenses

Surrender value payment

Net claim payments

Net amount of provisions for insurance contract liabilitiesrecognised

Policy dividend payments

Reinsurance expenses

Taxes and surcharges

Selling expenses

Administrative expenses

Research and development expenses

Finance expenses

Including: Interest expenses

Interest income

Add: Other income

Investment income (loss is expressed with “-”)

Including: Income from investments in associates and joint ventures

Income from the derecognition of financial assets measuredat amortised cost

Exchange gains (loss is expressed with “-”)

Net position hedging gains (loss is expressed with “-”)

Fair value gains (loss is expressed with “-”)

Credit impairment losses (loss is expressed with “-”)

Impairment losses of assets (loss is expressed with “-”)

Gains on disposal of assets (loss is expressed with “-”)

III. Operating profit (loss is expressed with “-”)

Add: Non-operating income

Less: Non-operating expenses

IV. Profit before income tax (loss is expressed with “-”)

Less: Income tax expenses

V. Profit (loss is expressed with “-”)

(I) Classified by continuity of operations

1. Profit from continuing operations (loss is expressed with “-”)

2. Profit from a discontinued operation (loss is expressed with “-”)

(II) Classified by ownership

1. Profit attributable to shareholders of the parent

2. Profit or loss attributable to non-controlling interests

VI. Net amount of other comprehensive income after tax

Other comprehensive income, net of tax, attributable to owners of the parent

(I) Other comprehensive income that will not be reclassified to profit or loss

1. Remeasurement of a defined benefit plan

2. Other comprehensive income using the equity method that will not be

reclassified to profit or loss

3. Change in the fair value of other equity investments

4. Change in the fair value of the entity’s own credit risks

5. Others

(II) Other comprehensive income that may be reclassified to profit or loss

1. Other comprehensive income using the equity method that may bereclassified to profit or loss

2. Change in the fair value of other debt investments

3. Amount recognised in other comprehensive income resulting from the

reclassification of financial assets

4. Provision for credit impairment of other debt investments

5. Cash flow hedge reserve

6. Exchange differences on translation of foreign currency financial

statements

7. Others

Other comprehensive income, net of tax, attributable to non-controlling interests

VII. Total comprehensive income for the period

Total comprehensive income attributable to owners of the parent

Total comprehensive income attributable to non-controlling interests

VIII. Earnings per share:

(I) Basic earnings per share

(II) Diluted earnings per share

For business combination involving entities under common control occurring during the current period, the net profit of the combined party generatedbefore the business combination is RMB0.00, and the net profit of the combined party generated for the prior period is RMB0.00.

4. Parent company’s income statement

Unit: RMB

I. Operating revenue

Less: Cost of sales

Taxes and surcharges

Selling expenses

Administrative expenses

Research and development expenses

Finance expenses

Including: Interest expenses

Interest income

Add: Other income

Investment income (loss is expressed with “-”)

Including: Income from investments in associates and joint ventures

Income from the derecognition of financial assets measured atamortised cost

Net position hedging gains (loss is expressed with “-”)

Fair value gains (loss is expressed with “-”)

Credit impairment losses (loss is expressed with “-”)

Impairment losses of assets (loss is expressed with “-”)

Gains on disposal of assets (loss is expressed with “-”)

II. Operating profit (loss is expressed with “-”)

Add: Non-operating income

Less: Non-operating expenses

III. Profit before income tax (loss is expressed with “-”)

Less: Income tax expenses

IV. Profit (loss is expressed with “-”)

(I) Profit from continuing operations (loss is expressed with “-”)

(II) Profit from a discontinued operation (loss is expressed with “-”)

V. Net amount of other comprehensive income after tax

(I) Other comprehensive income that will not be reclassified to profit orloss

1. Remeasurement of a defined benefit plan

2. Other comprehensive income using the equity method that will not be

reclassified to profit or loss

3. Change in the fair value of other equity investments

4. Change in the fair value of the entity’s own credit risks

5. Others

(II) Other comprehensive income that may be reclassified to profit or loss

1. Other comprehensive income using the equity method that may be

reclassified to profit or loss

2. Change in the fair value of other debt investments

3. Amount recognised in other comprehensive income resulting from the

reclassification of financial assets

4. Provision for credit impairment of other debt investments

5. Cash flow hedge reserve

6. Exchange differences on translation of foreign currency financial

statements

7. Others

VI. Total comprehensive income for the period

VII. Earnings per share:

(I) Basic earnings per share

(II) Diluted earnings per share

Legal representative: Li Jianquan

5. Consolidated statement of cash flows

Unit: RMB

I. CASH FLOWS FROM OPERATING ACTIVITIES:

Cash receipts from the sale of goods and the rendering of services

Net increase in customer deposits and deposits from banks and other financialinstitutions

Net increase in borrowings from the Central Bank

Net increase in placements from other financial institutions

Cash receipts for premium of original insurance contract

Net cash receipts for reinsurance business

Net increase in policyholders’ deposits and investment funds

Cash received from interest, fee and commission income

Net increase in placements from banks and other financial institutions

Net increase in funds for repurchase business

Net cash receipts for securities trading on agency basis

Receipts of taxes and surcharges refunds

Other cash receipts relating to operating activities

Total cash inows from operating activities

Cash payments for goods and services

Net increase in loans and advances to customers

Net increase in deposits with the Central Bank and other financial institutions

Cash payments for settlement of claims under the original insurance contract

Net increase in placements to banks and other financial institutions

Cash payments for interest, fee and commission expenses

Cash payments for insurance policy dividends

Cash payments to and on behalf of employees

Payments of taxes and surcharges

Other cash payments relating to operating activities

Total cash outows from operating activities

Net cash ows from operating activities

II. CASH FLOWS FROM INVESTING ACTIVITIES:

Cash receipts from returns of investments

Cash receipts from returns on investments

Net cash receipts from disposal of fixed assets, intangible assets and otherlong-term assets

Net cash receipts from disposal of subsidiaries and other business units

Other cash receipts relating to investing activities

Total cash inows from investing activities

Cash payments to acquire fixed assets, intangible assets and other long-termassets

Cash payments for investments

Net increase in pledged loans

Net cash payments for acquisition of subsidiaries and other business units

Other cash payments relating to other investing activities

Total cash outows from investing activities

Net cash ows from investing activities

III. CASH FLOWS FROM FINANCING ACTIVITIES:

Cash proceeds from investments by others

Including: Cash receipts from capital contributions from non-controllinginterests of subsidiaries

Cash receipts from borrowings

Other cash receipts relating to financing activities

Total cash inows from nancing activities

Cash repayments for debts

Cash payments for distribution of dividends or profit and interest expenses

Including: Dividends or profit paid to non-controlling shareholders ofsubsidiaries

Other cash payments relating to financing activities

Total cash outows from nancing activities

Net cash ows from nancing activities

IV. EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASHEQUIVALENTS

V. NET INCREASE IN CASH AND CASH EQUIVALENTS

Add: Cash and cash equivalents at beginning of period

VI. CLOSING BALANCE OF CASH AND CASH EQUIVALENTS

Legal representative: Li Jianquan

6. Parent company’s statement of cash flows

Unit: RMB

I. CASH FLOWS FROM OPERATING ACTIVITIES:

Cash receipts from the sale of goods and the rendering of services

Receipts of taxes and surcharges refunds

Other cash receipts relating to operating activities

Total cash inows from operating activities

Cash payments for goods and services

Cash payments to and on behalf of employees

Payments of taxes and surcharges

Other cash payments relating to operating activities

Total cash outows from operating activities

Net cash ows from operating activities

II. CASH FLOWS FROM INVESTING ACTIVITIES:

Cash receipts from returns of investments

Cash receipts from returns on investments

Net cash receipts from disposal of fixed assets, intangible assets and other long-term assets

Net cash receipts from disposal of subsidiaries and other business units

Other cash receipts relating to investing activities

Total cash inows from investing activities

Cash payments to acquire fixed assets, intangible assets and other long-term assets

Cash payments for investments

Net cash payments for acquisition of subsidiaries and other business units

Other cash payments relating to other investing activities

Total cash outows from investing activities

Net cash ows from investing activities

III. CASH FLOWS FROM FINANCING ACTIVITIES:

Cash proceeds from investments by others

Cash receipts from borrowings

Other cash receipts relating to financing activities

Total cash inows from nancing activities

Cash repayments for debts

Cash payments for distribution of dividends or profit and interest expenses

Other cash payments relating to financing activities

Total cash outows from nancing activities

Net cash ows from nancing activities

IV. EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASHEQUIVALENTS

V. NET INCREASE IN CASH AND CASH EQUIVALENTS

Add: Cash and cash equivalents at beginning of period

VI. CLOSING BALANCE OF CASH AND CASH EQUIVALENTS

Legal representative: Li Jianquan

7. Consolidated statement of changes in equity

Amount for the period

Unit: RMB

Items

Semiannual 2025

Attributable to owners of the parent

Attributable to owners of the parent

Non-controllinginterests

Non-controllinginterestsTotal equity

Total equity

Share capital

Share capital

Other equityinvestments

Other equityinvestments

Capital

reserves

Capital

reserves

Less:

Treasury

shares

Less:

Treasury

shares

Other

Other

comprehensiv

e income

Specialised

reserves

Specialised

reservesSurplusreserves

Surplusreserves

General reserve

General reserve

Unappropriate

d profit

Others

Others

Sub-total

Sub-total

Prefere

nce

shares

Perpet

ual

bondsOthers

Others

I. Balance at end of prior year

582,329,808.00

3,378,540,11

5.00

7,282,100.00

-2,637,827.10

420,212,778

.13

6,780,116,870.

11,151,279,644.

11,151,279,644.

724,391,558.18

11,875,671,202.

Add: Changes in accounting policies

Add: Changes in accounting policies

Correction of prior period errors

Correction of prior period errors

Others

Others

II. Balance at beginning of year

582,329,808.00

3,378,540,11

5.00

7,282,100.00

-2,637,827.10

420,212,778

.13

6,780,116,870.

11,151,279,644.

11,151,279,644.

724,391,558.18

11,875,671,202.

III. Changes for the period Amount

(Decrease is indicated by “

-”)

27,348,053.6

-88,375.00

-2,122,69334

346,415,557.0

371,729,292.38

371,729,292.38

28,558,934.56

400,288,226.94

(I) Total comprehensive income

-2,122,693.34

491,998,009.0

489,875,315,73

489,875,315,73

30,966,895.52

520,842,211.25

(II) Owners’ contributions andreduction in capital

(II) Owners’ contributions andreduction in capital

27,348,053.6

-88,375.00

27,436,428.65

27,436,428.65

150,000.00

27,586,428.65

1. Ordinary shares invested by

owners

1. Ordinary shares invested by

owners

150,000.00

150,000.00

2. Capital contributions from holders

of other equity instruments

2. Capital contributions from holders

of other equity instruments

3. Amount of share

-based paymentsrecognised in equity

3. Amount of share

-based paymentsrecognised in equity

27,348,053.6

27,348,053.65

27,348,053.65

27,348,053.65

4. Others

4. Others

-88,375.00

-88,375.00

88,375.00

88,375.00

88,375.00

88,375.00

(III) Profit distribution

-

145,582,452.0

-145,582,452.00

-145,582,452.00

-2,557,960.96

-148,140,412.96

1. Appropriation to surplus reserves

1. Appropriation to surplus reserves

Items

Semiannual 2025

Attributable to owners of the parent

Attributable to owners of the parent

Non-controllinginterests

Non-controllinginterestsTotal equity

Total equity

Share capital

Share capital

Other equity

investments

Capital

reserves

Capital

reservesLess:

Treasury

shares

Less:

Treasury

sharesOther

Other

comprehens

ive incomeSpecialised reserves

Specialised reservesSurplusreserves

SurplusreservesGeneral

reserve

General

reserveUnappropria

ted profit

Unappropria

ted profitOthers

OthersSub-total

Sub-total

Prefe

rence

share

s

Perpe

tual

bonds

Other

s

2. Appropriation to general

reserve

3. Distribution to owners (or

3. Distribution to owners (or

shareholders)

-

145,582,452

.00

-

145,582,452

.00

-

145,582,452.

-2,557,960.96

-2,557,960.96

-

148,140,412.9

4. Others

4. Others

(IV) Transfer within equity

(IV) Transfer within equity

1. Capitalisation of capital

reserves (or share capital)

1. Capitalisation of capital

reserves (or share capital)

2. Capitalisation of surplus

reserves (or share capital)

2. Capitalisation of surplus

reserves (or share capital)

3. Loss made up by surplus

reserves

3. Loss made up by surplus

reserves

4. Transfer of changes in the

defined benefit plan to retainedearnings

4. Transfer of changes in the

defined benefit plan to retainedearnings

5. Transfer of other

comprehensive income toretained earnings

5. Transfer of other

comprehensive income toretained earnings

6. Others

6. Others

(V) Specialised reserves

(V) Specialised reserves

1. Appropriation for the period

1. Appropriation for the period

2. Utilisation for the period

2. Utilisation for the period

(VI) Others

(VI) Others

IV. Balance at end of period

582,329,808.

3,405,888,1

68.65

7,193,725.

-

4,760,520.4

420,212,7

78.13

7,126,532,4

27.60

7,126,532,4

27.60

11,523,008,9

36.94

752,950,492.

752,950,492.

12,275,959,42

Amount for the prior year

Unit: RMB

Items

Semiannual 2024

Semiannual 2024

Attributable to owners of the parent

Attributable to owners of the parent

Non-

controlling

interests

Total equity

Total equity

Share capital

Share capital

Other equityinvestments

Other equityinvestments

Capitalreserves

CapitalreservesLess:

Treasury

shares

Less:

Treasury

shares

Other

comprehensive

income

Other

comprehensive

income

Specialise

d reservesSurplusreserves

SurplusreservesGeneralreserve

GeneralreserveUnappropria

ted profit

Unappropria

ted profit

Others

OthersSub-total

Sub-total

Prefe

rence

share

s

Perpe

tualbond

s

Other

s

I. Balance at end of prior year

594,387,367.

4,381,126,

487.29

473,552,4

42.85

2,215,369.4

2,215,369.4

420,212,7

78.13

6,608,834,7

68.99

6,608,834,7

68.99

11,533,224,3

28.00

577,097,475.

12,110,321,8

03.15

Add: Changes in accountingpolicies

Add: Changes in accountingpolicies

Correction of prior perioderrors

Correction of prior perioderrors

Others

Others

II. Balance at beginning of year

II. Balance at beginning of year

594,387,367.

4,381,126,

487.29

473,552,4

42.85

2,215,369.4

2,215,369.4

6,608,834,7

68.99

6,608,834,7

68.99

11,533,224,3

28.00

577,097,475.

12,110,321,8

03.15

III. Changes for the periodAmount(Decrease is indicated by “

-”)

III. Changes for the periodAmount(Decrease is indicated by “

-”)

-6,094,659.00

-

442,215,86

4.75

-

256,237,6

46.96

-

2,931,540.1

-

2,931,540.1

420,212,7

78.13

92,985,475.

92,985,475.

-

102,018,941.

22,739,880.3

-

79,279,061.3

(I) Total comprehensive income

(I) Total comprehensive income

-

2,931,540.1

-

2,931,540.1

384,150,379

.21

384,150,379

.21

381,218,839.

19,629,653.3

400,848,492.

(II) Owners’ contributions andreduction in capital

(II) Owners’ contributions andreduction in capital

2,908,958.

2,908,958.42

0.00

2,908,958.42

1. Ordinary shares invested by

owners

1. Ordinary shares invested by

owners

0.00

0.00

0.00

2. Capital contributions from

holders of other equityinstruments

2. Capital contributions from

holders of other equityinstruments

0.00

0.00

0.00

3. Amount of share

-based

payments recognised in equity

3. Amount of share

-based

payments recognised in equity

2,908,958.

2,908,958.42

0.00

2,908,958.42

4. Others

4. Others

0.00

0.00

0.00

0.00

0.00

0.00

(III) Profit distribution

(III) Profit distribution

-

291,164,904

.00

-

291,164,904

.00

-291,164,904.

0.00

-

291,164,904.

1. Appropriation to surplus

reserves

1. Appropriation to surplus

reserves

0.00

0.00

0.00

Items

Semiannual 2024

Semiannual 2024

Attributable to owners of the parent

Attributable to owners of the parent

Non-

controllinginterests

Non-

controllinginterestsTotal equity

Total equity

Share capital

Share capital

Other equityinvestments

Other equityinvestments

Capitalreserves

CapitalreservesLess:

Treasuryshares

Less:

TreasurysharesOther

Other

comprehen

siveincome

Specialise

d reservesSurplusreserves

SurplusreservesGeneralreserve

GeneralreserveUnappropria

ted profit

Unappropria

ted profit

Others

OthersSub-total

Sub-total

Prefe

rence

share

s

Perpetualbond

s

Other

s

2. Appropriation to general

reserve

0.00

0.00

0.00

0.00

0.00

3. Distribution to owners (or

shareholders)

3. Distribution to owners (or

shareholders)

-

291,164,904

.00

-

291,164,904

.00

-

291,164,904.

0.00

0.00

-

291,164,904.

-

291,164,904.

4. Others

4. Others

0.00

0.00

0.00

0.00

0.00

0.00

(IV) Transfer within equity

(IV) Transfer within equity

-6,094,659.00

-

445,124,82

3.17

-

451,219,4

82.17

-

451,219,4

82.17

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

1. Capitalisation of capital

reserves (or share capital)

1. Capitalisation of capital

reserves (or share capital)

0.00

0.00

0.00

0.00

0.00

2. Capitalisation of surplus

reserves (or share capital)

2. Capitalisation of surplus

reserves (or share capital)

0.00

0.00

0.00

0.00

0.00

3. Loss made up by surplus

reserves

3. Loss made up by surplus

reserves

0.00

0.00

0.00

0.00

0.00